MRL-37
MRL-37
MRL-37 is a synthetic peptide with potential antimicrobial properties. It is part of a class of peptides known as antimicrobial peptides (AMPs), which are being studied for their ability to combat bacterial infections, particularly those caused by antibiotic-resistant strains.
Structure and Composition[edit | edit source]
MRL-37 is a cationic peptide, meaning it carries a positive charge. This characteristic is crucial for its interaction with the negatively charged components of bacterial cell membranes. The peptide is composed of 37 amino acids, which are arranged in a sequence that allows it to adopt an amphipathic structure. This structure is essential for its ability to insert into and disrupt bacterial membranes.
Mechanism of Action[edit | edit source]
The primary mechanism by which MRL-37 exerts its antimicrobial effects is through membrane disruption. Upon contact with bacterial cells, MRL-37 binds to the membrane and integrates into the lipid bilayer. This integration leads to the formation of pores or channels, resulting in the leakage of cellular contents and ultimately cell death. This mode of action is distinct from that of traditional antibiotics, which often target specific bacterial enzymes or pathways.
Potential Applications[edit | edit source]
MRL-37 is being investigated for its potential use in treating infections caused by multi-drug resistant bacteria. Its ability to disrupt bacterial membranes makes it a promising candidate for use against a broad spectrum of bacteria, including Gram-positive and Gram-negative strains. Additionally, MRL-37 may have applications in the development of topical treatments for skin infections and as a preservative in various products due to its antimicrobial properties.
Research and Development[edit | edit source]
Research on MRL-37 is ongoing, with studies focusing on optimizing its stability, efficacy, and safety for potential therapeutic use. Challenges in the development of MRL-37 include ensuring its selective toxicity towards bacterial cells over human cells and improving its stability in physiological conditions.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD